Page last updated: 2024-08-24

lisofylline and Insulin Sensitivity

lisofylline has been researched along with Insulin Sensitivity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abdelzaher, LA; Ali, M; Bakr, MH; Desai, AA; Mali, V; Radwan, E; Sayed, SA	1

Other Studies

1 other study(ies) available for lisofylline and Insulin Sensitivity

Article	Year
Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway. Cytokine, 2021, Volume: 138 Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Body Weight; Disease Models, Animal; Heart; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Myocardium; Obesity; Pentoxifylline; Signal Transduction; Up-Regulation	2021

Article

Year

Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway.

Cytokine, 2021, Volume: 138

Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Body Weight; Disease Models, Animal; Heart; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Myocardium; Obesity; Pentoxifylline; Signal Transduction; Up-Regulation

2021